News and Press Releases
Research | About the CF Foundation | Clinical Trials CF Foundation Awards Up to $2M to Eloxx for Additional Support for Studies into Nonsense Mutations Therapy

Today, the Cystic Fibrosis Foundation announced a new award of up to $2 million to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy to treat people with cystic fibrosis who have nonsense mutations.

June 13, 2021 | 4 min read
Clinical Trials First-of-Its-Kind Study Uses Smartphone to Track Cystic Fibrosis in Real Life

Observational study supported by the CF Foundation will monitor real-world experience with Trikafta

June 2, 2021 | 4 min read